GlobeNewswire Inc.··Novo NordiskNovo Nordisk Invests €432M in Irish Plant to Boost GLP-1 Drug Output
Novo Nordisk invests €432M in Irish manufacturing expansion to boost oral GLP-1 drug production capacity, targeting completion by 2028.
NVOmanufacturing expansioninvestment